Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandip Basu

Showing results (51-60 of 519) with videos related to

Pageof 52
Sort By:
Nuclear Medicine Communications|April 23, 2016
Observation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: is redifferentiation akin phenomenon a reality in neuroendocrine tumors?Sandip Basu, Vikas Ostwal
Nuclear Medicine Communications|September 14, 2017
Volumetric high-resolution computed tomography in evaluating pulmonary metastases from differentiated thyroid carcinoma: considerations for evolving the optimal diagnostic pathwaySandip Basu, Ashwini Kalshetty
Journal of Nuclear Medicine Technology|September 17, 2016
177Lu-DOTATATE PRRT in Recurrent Skull-Base Phosphaturic Mesenchymal Tumor Causing Osteomalacia: A Potential Application of PRRT Beyond Neuroendocrine TumorsSandip Basu, Preeti Fargose
Neuroimaging Clinics of North America|December 5, 2009
Molecular imaging (PET) of brain tumorsSandip Basu, Abass Alavi
European Journal of Nuclear Medicine and Molecular Imaging|February 18, 2015
Ursodeoxycholic acid versus phenobarbital pretreatment prior to hepatobiliary scintigraphy in neonatal cholestasis: is it time for shifting gears towards a practice change?Sandip Basu, Anish Bhattacharya
Clinical Nuclear Medicine|August 9, 2016
68Ga DOTATATE PET/CT in Differentiated Thyroid Carcinoma With Fibular Metastasis and Mixed Response to SorafenibSandip Basu, Amit Joshi
Clinical Nuclear Medicine|June 5, 2026
Theranostics and Molecular-targeted Endo-radiotherapy: The Current Landscape and Future DirectionsAamir Nazar, Sandip Basu
Diagnostics (Basel, Switzerland)|January 8, 2023
PSMA Receptor-Based PET-CT: The Basics and Current Status in Clinical and Research ApplicationsAadil Adnan, Sandip Basu
Journal of Nuclear Medicine Technology|September 6, 2014
The use of 99mTc-HYNIC-TOC and 18F-FDG PET/CT in the evaluation of duodenal neuroendocrine tumor with atypical and extensive metastasis responding dramatically to a single fraction of PRRT with 177Lu-DOTATATESandip Basu, Amit Abhyankar
Journal of Cancer Research and Therapeutics|October 14, 2015
Thymus uptake of 131I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practiceAmit Abhyankar, Sandip Basu
Pageof 52

Showing results (51-60 of 519) with videos related to

Sort By:
Pageof 52
Nuclear Medicine Communications|April 23, 2016
Observation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: is redifferentiation akin phenomenon a reality in neuroendocrine tumors?Sandip Basu, Vikas Ostwal
Nuclear Medicine Communications|September 14, 2017
Volumetric high-resolution computed tomography in evaluating pulmonary metastases from differentiated thyroid carcinoma: considerations for evolving the optimal diagnostic pathwaySandip Basu, Ashwini Kalshetty
Journal of Nuclear Medicine Technology|September 17, 2016
177Lu-DOTATATE PRRT in Recurrent Skull-Base Phosphaturic Mesenchymal Tumor Causing Osteomalacia: A Potential Application of PRRT Beyond Neuroendocrine TumorsSandip Basu, Preeti Fargose
Neuroimaging Clinics of North America|December 5, 2009
Molecular imaging (PET) of brain tumorsSandip Basu, Abass Alavi
European Journal of Nuclear Medicine and Molecular Imaging|February 18, 2015
Ursodeoxycholic acid versus phenobarbital pretreatment prior to hepatobiliary scintigraphy in neonatal cholestasis: is it time for shifting gears towards a practice change?Sandip Basu, Anish Bhattacharya
Clinical Nuclear Medicine|August 9, 2016
68Ga DOTATATE PET/CT in Differentiated Thyroid Carcinoma With Fibular Metastasis and Mixed Response to SorafenibSandip Basu, Amit Joshi
Clinical Nuclear Medicine|June 5, 2026
Theranostics and Molecular-targeted Endo-radiotherapy: The Current Landscape and Future DirectionsAamir Nazar, Sandip Basu
Diagnostics (Basel, Switzerland)|January 8, 2023
PSMA Receptor-Based PET-CT: The Basics and Current Status in Clinical and Research ApplicationsAadil Adnan, Sandip Basu
Journal of Nuclear Medicine Technology|September 6, 2014
The use of 99mTc-HYNIC-TOC and 18F-FDG PET/CT in the evaluation of duodenal neuroendocrine tumor with atypical and extensive metastasis responding dramatically to a single fraction of PRRT with 177Lu-DOTATATESandip Basu, Amit Abhyankar
Journal of Cancer Research and Therapeutics|October 14, 2015
Thymus uptake of 131I in patients with differentiated thyroid carcinoma: Three different case scenarios and patterns of uptake and the importance of its recognition in thyroid cancer practiceAmit Abhyankar, Sandip Basu
Pageof 52